Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Neo GBR System

K-Number: K160991 · 2017-01-10

Decision Date2017-01-10
Product CodeDZL
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

Neo GBR System is a medical device manufactured by Neobiotech Co., Ltd.. It received FDA 510(k) clearance on 2017-01-10 under approval number K160991. The device is classified under product code DZL. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Neo GBR System?

Neo GBR System is a medical device that received FDA 510(k) clearance on 2017-01-10. It is manufactured by Neobiotech Co., Ltd.. The 510(k) number is K160991.

When was Neo GBR System approved by the FDA?

Neo GBR System received FDA 510(k) clearance on 2017-01-10, under approval number K160991.

What company makes Neo GBR System?

Neo GBR System is manufactured by Neobiotech Co., Ltd..

What is the FDA product code for Neo GBR System?

The FDA product code for Neo GBR System is DZL.

Other Devices by Neobiotech Co., Ltd.

View all 9 devices →

Related Devices (Code: DZL)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.